MLV based viral-like-particles for delivery of toxic proteins and nuclear transcription factors.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24997480.
- Also identified by DOI 10.1016/j.biomaterials.2014.06.006 and PMC identifier 4139071.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We have developed nanoparticles based on Murine Leukemia Virus virus-like-particles (VLPs) that efficiently deliver therapeutic bioactive proteins in their native state into target cells. Nuclear transcription factors and toxic proteins were incorporated into the VLPs from stable producer cells without transducing viral-encoded genetic material. Delivery of nuclear transcription factors required incorporation of nuclear export signals (NESs) into the vector backbone for the efficient formation of VLPs. In the presence of an appropriate targeting Env glycoprotein, transcription factors delivered and activated nuclear transcription in the target cells. Additionally, we show delivery of the bacterial toxin, MazF, which is an ACA-specific mRNA interferase resulted in the induction of cell death. The stable producer cells are protected from the toxin through co-expression of the anti-toxin MazE and continuously released MazF incorporating VLPs. This highly adaptable platform can be harnessed to alter and regulate cellular processes by bioactive protein delivery.
Medical subject headings
- Bacterial Toxins
- Cell Nucleus
- Genetic Vectors
- Leukemia Virus, Murine
- Transcription Factors
- Virion